TCR2 Therapeutics Inc.
TCRR · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$40,399 | -$60,505 | -$30,594 | -$31,601 |
| Dep. & Amort. | $615 | $746 | $890 | $704 |
| Deferred Tax | $0 | $0 | $0 | -$314 |
| Stock-Based Comp. | $579 | $2,663 | $2,693 | $2,847 |
| Change in WC | -$3,374 | $5,088 | $1,435 | $8,993 |
| Other Non-Cash | $2,569 | $27,051 | -$263 | -$160 |
| Operating Cash Flow | -$40,010 | -$24,957 | -$25,839 | -$19,531 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$158 | -$2,441 | -$4,823 | -$6,211 |
| Net Acquisitions | $0 | $15,452 | $0 | $0 |
| Inv. Purchases | -$13,699 | -$51,903 | -$29,613 | -$37,624 |
| Inv. Sales/Matur. | $35,000 | $58,000 | $69,998 | $33,501 |
| Other Inv. Act. | $543 | -$15,452 | $0 | $0 |
| Investing Cash Flow | $21,686 | $3,656 | $35,562 | -$10,334 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $34 | $256 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $24 | $41 | $72 | -$47 |
| Financing Cash Flow | $24 | $41 | $72 | -$47 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$18,300 | -$21,260 | $9,795 | -$29,912 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $33,898 | $55,158 | $45,363 | $75,275 |
| End Cash | $15,598 | $33,898 | $55,158 | $45,363 |
| Free Cash Flow | -$40,168 | -$27,398 | -$30,662 | -$25,742 |